ArticleMethods in molecular biology (Clifton, N.J.)2025
Analyzing Topoisomerase II Cleavage Complexes Using Flow Cytometry.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Flow cytometry is a powerful technique used in biology and medicine to analyze and quantify characteristics of individual cells in a heterogeneous population. It provides information about various cellular properties, such as size, complexity, surface markers, and internal components. We developed a flow cytometry-based method for the analysis of drug-induced topoisomerase II cleavage complex (Top2cc). This method allows a rapid analysis of a high number of cells in their cell cycle phase context. Moreover, it can be applied to almost any human cell type, including clinical samples. The methodology is valuable for conducting high-throughput analyses of drugs that target Top2, enabling the discrimination of the specific isoform affected, and tracking its removal. Since drug-stabilized Top2cc may interfere with several nuclear processes of DNA, this method allows the study of different pathways that may be hampered, evaluating their impact under different cellular conditions.
Indexed as
Identifiers
40372646What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.